Conference - Washington, DC, United States
Arrowhead's Annual Pain and Migraine Therapeutics Summit is the US’s premier pain conference covering the field of pain research and therapeutics. Leaders from the pharmaceutical, biotech, device and medical communities attend this conference to learn about the latest advances in the treatment of various types of pain and to network with colleagues from industry, the non-profit sector, academia, the medical community, government and investors.
This conference provides attendees with thoughtful insight from key industry leaders and academic researchers concerning cutting edge drug discovery science, preclinical development trends, analysis of key clinical-stage pain therapies and newly marketed products. We will highlight the most important developments in recent years in the field, including new research in genome-wide association studies, CGRP antagonists, NGF antagonists, sodium and calcium channel blockers, new research in biologic therapies, the genetic components of pain, abuse-resistant opioids, analysis of FDA’s REMS program and a plethora of other topics.
- Organization: Arrowhead Publishers and Conferences
Wed, Sep 23, 2015 - Thu, Sep 24, 2015
Washington, DC, United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
